Royalty Pharma plc (RPRX): Share Repurchases

Annual figures by period end, from SEC filings.

$1.23B
Year ended 2025-12-31
$321.77M
Trailing 12 months to 2026-06-30
2018-12-31: $02019-12-31: $4.27M2020-12-31: $02021-12-31: $02022-12-31: $02023-12-31: $304.76M2024-12-31: $229.65M2025-12-31: $1.23B$1.23B
2018-12-31 Share Repurchases (USD) 2025-12-31
Period endedShare RepurchasesChange YoYSource filing
2025-12-31$1.23B+434.5%2026-02-11, From 2025-01-01
2024-12-31$229.65M-24.6%2026-02-11, From 2024-01-01
2023-12-31$304.76Mn/a2026-02-11, From 2023-01-01
2022-12-31$0n/a2025-02-12, From 2022-01-01
2021-12-31$0n/a2024-02-15, From 2021-01-01
2020-12-31$0-100.0%2022-02-15, From 2020-01-01
2019-12-31$4.27Mn/a2022-02-15, From 2019-01-01
2018-12-31$0n/a2021-02-24, From 2018-01-01

Share Repurchases at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShare RepurchasesChange YoY
Royalty Pharma plc (RPRX)2025-12-31$1.23B+434.5%
Sarepta Therapeutics, Inc. (SRPT)2025-12-31$25.01Mn/a
United Therapeutics Corp (UTHR)2025-12-31$1.00B0.0%
Alkermes plc. (ALKS)2024-12-31$200.28Mn/a
Jazz Pharmaceuticals plc (JAZZ)2025-12-31$125.02M-59.9%
Indivior Pharmaceuticals, Inc. (INDV)2025-12-31$11.00M-93.6%
Prestige Consumer Healthcare Inc. (PBH)2026-03-31$156.28M+203.4%
ANI Pharmaceuticals Inc (ANIP)2025-12-31$12.21M+11.4%
Collegium Pharmaceutical, Inc (COLL)2025-12-31$25.10M-58.2%

Compare RPRX, SRPT, UTHR, ALKS side by side · Screen every company in Pharmaceutical Preparations ↗